Lomexin Cream is a topical antifungal medication that contains fenticonazole nitrate as its active ingredient. It belongs to the azole class of antifungals and is formulated as a 30 g tube for cutaneous application. In Hong Kong, the product is available by prescription and is regulated by the Department of Health. The cream is intended for the treatment of fungal skin infections and related inflammatory conditions.
Fenticonazole nitrate exerts its antifungal effect by inhibiting the enzyme lanosterol 14α-demethylase, a key step in the synthesis of ergosterol, an essential component of fungal cell membranes. Without sufficient ergosterol, the fungal cell membrane becomes unstable, leading to impaired growth and cell death. The drug is absorbed minimally through intact skin, concentrating its activity at the site of infection while limiting systemic exposure.
Lomexin Cream is approved in Hong Kong for the topical treatment of the following dermatological conditions:
These indications reflect the drug’s activity against dermatophytes and yeasts that commonly cause superficial skin infections.
Patients with extensive skin lesions, open wounds, or compromised barrier function should consult a healthcare professional before use.
Topical fenticonazole nitrate has limited systemic absorption, reducing the likelihood of drug-drug interactions. Nevertheless, patients should inform their healthcare provider of all concurrent medications, especially systemic azole antifungals, as additive antifungal effects could increase the risk of local irritation.
Missed dose: Apply the missed dose as soon as remembered, unless it is close to the time of the next scheduled application; in that case, skip the missed dose and resume the regular schedule. Do not double the dose.
Overdose: Systemic overdose is unlikely. If large amounts are applied inadvertently, wash the area with mild soap and water and seek medical advice if irritation persists.
Discontinuation: No tapering is required. Stop the product after completing the prescribed course or if a serious adverse reaction occurs.
Clinical response should be evaluated after 1-2 weeks of therapy. If there is no improvement or if the infection worsens, patients should contact their healthcare provider for possible alternative treatments or extended therapy.
This article provides educational information about Lomexin Cream and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Lomexin Cream is formulated for skin infections and is not indicated for onychomycosis (nail fungus). Nail infections typically require systemic therapy or specialized nail formulations.
Safety in children under 2 years has not been established. Use in this age group should only occur under direct medical supervision.
Mild transient burning is common. If the sensation persists or worsens, wash the area with mild soap and water and seek advice from a healthcare professional.
The topical cream does not affect physical performance. However, ensure the treated area is fully dry before engaging in activities that cause excessive sweating to prevent dilution of the product.
Yes, it is a prescription-only medication regulated by the Hong Kong Department of Health.
Check the expiration date on the packaging and inspect the cream for any changes in color, texture, or odor. Discontinue use if any abnormalities are observed.
Topical application results in minimal systemic absorption, making it unlikely to be detected in standard drug-screening tests.
Concurrent use may increase the risk of skin irritation. Consult a healthcare provider before combining treatments.
Lomexin Cream contains fenticonazole nitrate, which has a broader spectrum against dermatophytes and yeasts compared with many OTC azoles. It is also prescribed for more extensive or resistant infections.
Yes, a 30 g tube complies with most airline liquid restrictions. Ensure the tube is sealed and labeled, and keep the prescription documentation in case customs requests verification.
